CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV…

Overview of attention for article published in Vaccine, June 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 8 patents

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Methods and compositions for enhancing vaccine immune responses

Grant US-10973892-B2

United States of America

13 Apr 2021

Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

Grant US-10729754-B2

United States of America

04 Aug 2020

Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

Grant US-10272143-B2

United States of America

30 Apr 2019

Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made…

Grant US-10006050-B2

United States of America

26 Jun 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.